NCT02767310View on ClinicalTrials.gov

Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet)

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Healthy
Interventions
DRUG

Rosuvastatin 20 mg film-coated tablets

Single oral dose of 20 mg

DRUG

Crestor 20 mg film-coated tablets

Single oral dose of 20 mg

Trial Locations (1)

380056

Synchron Research Services Pvt. Ltd., Ahmedabad

All Listed Sponsors
lead

Verisfield UK Ltd. Greek Branch

INDUSTRY

NCT02767310 - Study to Determine the Bioequivalence of Two Products Containing Rosuvastatin (20 mg/Tablet) | Biotech Hunter | Biotech Hunter